Overweight, obesity, and blood pressure: the effects of modest weight reduction (Q33930674)

30 July 2017

1 reference

title

Overweight, obesity, and blood pressure: the effects of modest weight reduction (English)

1 reference

30 July 2017

0 references

Mertens IL

1

1 reference

PubMed ID

10832771

30 July 2017

Van Gaal LF

series ordinal

2

1 reference

30 July 2017

1 May 2000

1 reference

30 July 2017

1 reference

30 July 2017

8

1 reference

30 July 2017

3

1 reference

30 July 2017

270-278

1 reference

Weight and blood pressure. Findings in hypertension screening of 1 million Americans

30 July 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Precursors of essential hypertension: body weight, alcohol and salt use, and parental history of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Improvements in blood pressure, glucose metabolism, and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

The independent and combined effects of weight loss and aerobic exercise on blood pressure and oral glucose tolerance in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Beneficial effect of a moderately energy-restricted diet on fibrinolytic factors in non-obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Effect of dexfenfluramine treatment on body weight, blood pressure and noradrenergic activity in obese hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Obesity and hypertension: epidemiological and clinical issues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

A prospective study of obesity and risk of coronary heart disease in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Short-term medical benefits and adverse effects of weight loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Longitudinal study of blood pressure: changes and determinants from adolescence to middle age. The Dormont High School follow-up study, 1957-1963 to 1989-1990.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Body weight, weight change, and risk for hypertension in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Adiposity, fat distribution, and cardiovascular risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Decrease in intra-abdominal visceral fat may reduce blood pressure in obese hypertensive women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Abdominal adiposity in six populations of West African descent: prevalence and population attributable fraction of hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Improved psychological well-being, quality of life, and health practices in moderately overweight women participating in a 12-week structured weight loss program

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Nonpharmacologic approaches to therapy for hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Blood pressure and hormone changes associated with weight reduction in the obese

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Cardiovascular Changes After Weight Reduction in Obesity Hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Sustained coronary-risk-factor reduction after gastric bypass for morbid obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

The Effects on Plasma Lipoproteins of a Prudent Weight-Reducing Diet, with or without Exercise, in Overweight Men and Women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Weight gain as a risk factor for clinical diabetes mellitus in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Implications of small reductions in diastolic blood pressure for primary prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Pharmacological treatment of obesity: present status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Blood pressure and plasma norepinephrine responses to dexfenfluramine in obese postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Sibutramine produces dose-related weight loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Obesity and hypertension: from pathophysiology to treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

Hypertension: comparison of drug and non-drug treatments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

inferred from DOI database lookup

7 January 2021

based on heuristic

What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.32

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2000.32

1 reference

30 July 2017

1 reference

PubMed ID

10832771